Radiology in the immune checkpoint inhibitor era

被引：0
|
作者：
Park, Benjamin C. [1 ,4 ]
Johnson, Douglas B. [2 ]
Lewandowski, Robert J. [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Gen Surg, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Northwestern Mem Hosp, Dept Radiol, Chicago, IL 60611 USA
[4] Vanderbilt Univ, Med Ctr, 1161 21st Ave Med Ctr North,D-5203, Nashville, TN 37232 USA
来源：
CLINICAL IMAGING | 2024年 / 107卷
关键词：
Immune checkpoint inhibitors; Interventional oncology; Immune related adverse events; Oncologic imaging;
D O I：
10.1016/j.clinimag.2024.110080
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
    Yi-xuan Yu
    Shuo Wang
    Zhe-ning Liu
    Xu Zhang
    Zi-xin Hu
    Hui-jing Dong
    Xing-yu Lu
    Jia-bin Zheng
    Hui-juan Cui
    Chinese Medicine, 18
  • [22] Back to the Future: Rethinking and Retooling IL2 in the Immune Checkpoint Inhibitor Era
    Sullivan, Ryan J.
    CANCER DISCOVERY, 2019, 9 (06) : 694 - 695
  • [23] Renal dysfunction in the immune checkpoint inhibitor era in lung cancer: challenges in differential diagnosis
    Rajput, Z.
    Bulusu, V.
    Aslam, S.
    Jeffs, Y.
    LUNG CANCER, 2020, 139 : S55 - S56
  • [24] Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
    Yu, Yi-xuan
    Wang, Shuo
    Liu, Zhe-ning
    Zhang, Xu
    Hu, Zi-xin
    Dong, Hui-jing
    Lu, Xing-yu
    Zheng, Jia-bin
    Cui, Hui-juan
    CHINESE MEDICINE, 2023, 18 (01)
  • [25] Neutrophils in the era of immune checkpoint blockade
    Faget, Julien
    Peters, Solange
    Quantin, Xavier
    Meylan, Etienne
    Bonnefoy, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [26] Immune Checkpoint Inhibitor Colitis, a Rising Issue in Targeted Cancer Therapy Era: A Literature Review
    Adiwinata, Randy
    Tandarto, Kevin
    Tanadi, Caroline
    Waleleng, Bradley Jimmy
    Haroen, Harlinda
    Rotty, Linda
    Gosal, Fandy
    Rotty, Luciana
    Hendratta, Cecilia
    Lasut, Pearla
    Winarta, Jeanne
    Waleleng, Andrew
    Simadibrata, Paulus
    Simadibrata, Marcellus
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2024, 62 (03) : 219 - 230
  • [27] Chronic immune checkpoint inhibitor pneumonitis
    Naidoo, Jarushka
    Cottrell, Tricia R.
    Lipson, Evan J.
    Forde, Patrick M.
    Illei, Peter B.
    Yarmus, Lonny B.
    Voong, K. Ranh
    Feller-Kopman, David
    Lee, Hans
    Riemer, Joanne
    Wang, Daphne
    Taube, Janis M.
    Brahmer, Julie R.
    Lin, Cheng Ting
    Danoff, Sonye K.
    D'Alessio, Franco R.
    Suresh, Karthik
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [28] Management of Immune Checkpoint Inhibitor Toxicities
    Durrechou, Quentin
    Domblides, Charlotte
    Sionneau, Baptiste
    Lefort, Felix
    Quivy, Amandine
    Ravaud, Alain
    Gross-Goupil, Marine
    Daste, Amaury
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 9139 - 9157
  • [29] NAFLD in Slenderness by Immune Checkpoint Inhibitor
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2020, 29 (02): : 130 - 130
  • [30] Immune checkpoint inhibitor associated diarrhoea
    Al-Hussainy, Amin
    Adams, Joss
    Simmons, Jon
    Kennedy, James
    BMJ CASE REPORTS, 2024, 17 (05)
12345